Lastacaft
alcaftadine · Solution/ Drops · Ophthalmic
Uses
1 INDICATIONS AND USAGE LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. ( 1 )
Dosage and administration
Instill one drop in each eye once daily. If more than 1 topical ophthalmic medicinal product is being used, each one should be administered at least 5 minutes apart. Instill one drop in each eye once daily. ( 2 )
Label text from the FDA structured product label by Allergan, Inc. (revised Jun 1, 2020). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Alcaftadine in 2 products
Lastacaft NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 0023-4290 | Alcaftadine 2.5 mg/mL Solution/ Drops | Allergan, Inc. | NDA |
| 0023-4291 | Alcaftadine 2.5 mg/mL Solution/ Drops | Allergan, Inc. | NDA |
Frequently asked questions
What is Lastacaft used for?
1 INDICATIONS AND USAGE LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. ( 1 )
Who makes Lastacaft?
Lastacaft is listed by 1 labeler in the FDA NDC directory, including Allergan, Inc..